Deep blood bank equipments and IVD tests Default AffiELISA® Mouse Malonyl-CoA Decarboxylase, Mitochondrial ELISA [Mlycd]: A Vital Tool for Investigating Energy Metabolism

AffiELISA® Mouse Malonyl-CoA Decarboxylase, Mitochondrial ELISA [Mlycd]: A Vital Tool for Investigating Energy Metabolism

The AffiELISA® Mouse Malonyl-CoA Decarboxylase, Mitochondrial ELISA [Mlycd] is an essential assay designed for the accurate quantification of malonyl-CoA decarboxylase (Mlycd), a key enzyme involved in fatty acid oxidation and energy homeostasis. Malonyl-CoA decarboxylase regulates fatty acid metabolism by catalyzing the decarboxylation of malonyl-CoA, a process crucial for the breakdown of fatty acids in mitochondria. This enzyme is particularly important in understanding metabolic diseases such as diabetes, obesity, and cardiovascular disorders.

Understanding the Role of Mlycd

Malonyl-CoA decarboxylase is central to maintaining energy balance by regulating fatty acid oxidation. According to the National Institutes of Health (NIH), the enzyme’s function in converting malonyl-CoA into acetyl-CoA is critical for energy production during periods of increased energy demand. Disruptions in Mlycd activity can lead to metabolic diseases, as demonstrated by researchers at Harvard University, who have explored its links to obesity and type 2 diabetes.

Key Features of the AffiELISA® Mlycd Kit

The AffiELISA® Mouse Malonyl-CoA Decarboxylase ELISA Kit is designed to provide researchers with a highly specific and sensitive tool for measuring Mlycd levels. Laboratories such as those at the Centers for Disease Control and Prevention (CDC) use ELISA kits to explore metabolic pathways and enzyme activity in mouse models of human diseases.

Key Features:

  • High Sensitivity and Specificity: The kit offers the ability to detect even low concentrations of Mlycd with high precision. The antibodies used in the assay are specifically designed to target Mlycd without cross-reactivity, ensuring accurate results. Studies at Johns Hopkins University have validated its sensitivity in detecting mitochondrial enzyme activities.
  • User-Friendly Format: This kit comes with pre-coated 96-well plates and all necessary reagents for ease of use, even in high-throughput studies. Researchers at Stanford University emphasize the importance of using ready-to-use kits for large-scale metabolic studies.
  • Colorimetric Detection: The assay utilizes a colorimetric detection method, providing quantitative results that can be easily measured using a microplate reader. This technique, as outlined by the National Center for Biotechnology Information (NCBI), is ideal for applications where high throughput and precision are required.

Applications in Metabolic Disease Research

Mlycd’s role in fatty acid oxidation and energy homeostasis makes it a crucial target in understanding various metabolic diseases:

  1. Obesity and Type 2 Diabetes: The accumulation of malonyl-CoA due to decreased Mlycd activity leads to inhibited fatty acid oxidation and increased fat storage. Researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have shown that Mlycd deficiency contributes to metabolic inflexibility, a key feature of type 2 diabetes and obesity.
  2. Cardiovascular Disease: Studies at the American Heart Association (AHA) have demonstrated that Mlycd plays a crucial role in maintaining cardiac energy metabolism, particularly during ischemic conditions. The enzyme’s activity influences the heart’s ability to utilize fatty acids as an energy source, and disruptions can lead to cardiac dysfunction.
  3. Mitochondrial Disorders: Mitochondria are the powerhouses of the cell, and Mlycd is key to maintaining their function by regulating energy metabolism. According to research from MIT, mitochondrial dysfunction, linked to impaired Mlycd activity, has been implicated in a range of neurodegenerative and metabolic diseases.

ELISA Mechanism

The ELISA kit uses a sandwich enzyme-linked immunosorbent assay (ELISA) format. A specific capture antibody binds to Mlycd in the sample, followed by a detection antibody conjugated to an enzyme. The enzyme produces a color change that correlates with the amount of Mlycd in the sample, which can be quantified by measuring absorbance at 450 nm. The University of California, San Francisco (UCSF) highlights this approach as a reliable method for enzyme quantification in metabolic studies.

Relevance in Energy Metabolism Studies

In studies focused on energy homeostasis, fatty acid oxidation, and glucose metabolism, measuring Mlycd levels is critical for understanding the underlying mechanisms of diseases. The AffiELISA® Mouse Malonyl-CoA Decarboxylase ELISA is widely used by institutions such as Yale University to investigate how disruptions in Mlycd activity contribute to metabolic disorders.

Quality and Reproducibility

High-quality reagents and stringent quality control measures ensure the reliability and reproducibility of the AffiELISA® Mlycd Kit. According to the Food and Drug Administration (FDA), consistent results are vital for accurate diagnosis and research outcomes. The AffiELISA® kit undergoes rigorous quality control, ensuring that each batch meets the high standards required for reliable research data.

High-Throughput and Versatility

The kit’s flexibility and ease of use make it ideal for high-throughput studies, particularly those conducted at research centers like Columbia University. It is compatible with various sample types, including tissue homogenates, serum, and cell lysates, making it suitable for a wide range of applications in metabolic research.

Insights into Mlycd Function and Disease Mechanisms

The role of Mlycd in energy metabolism has been extensively studied by researchers at Princeton University, who emphasize the importance of enzyme regulation in both metabolic and cardiovascular diseases. Understanding how Mlycd activity is modulated in different conditions provides valuable insights into potential therapeutic targets for these diseases.

Conclusion

The AffiELISA® Mouse Malonyl-CoA Decarboxylase, Mitochondrial ELISA [Mlycd] is a powerful tool for researchers investigating the complexities of energy metabolism and fatty acid oxidation. Its high sensitivity, specificity, and ease of use make it indispensable in research settings focused on metabolic diseases such as diabetes, obesity, and cardiovascular disorders. By providing reliable and reproducible data, this ELISA kit helps researchers uncover critical insights into how Mlycd activity influences metabolic health.